FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1845472102> ?p ?o ?g. }

• W1845472102 endingPage "3407" @default.
• W1845472102 startingPage "3401" @default.
• W1845472102 abstract "Abstract p53 is overexpressed by half of all cancers, and is an attractive target for a vaccine approach to immunotherapy. p53 overexpression is frequently the result of point mutations, which leaves the majority of the protein in its wild-type form. Therefore, the majority of p53 sequence is wild type, making it a self-protein for which tolerance plays a role in limiting immune responses. To overcome tolerance to p53, we have expressed wild-type murine p53 in the nonpathogenic attenuated poxvirus, modified vaccinia virus Ankara (recombinant modified vaccinia virus Ankara expressing wild-type murine p53 (rMVAp53)). Mice immunized with rMVAp53 vaccine developed vigorous p53-specific CTL responses. rMVAp53 vaccine was evaluated for its ability to inhibit the outgrowth of the syngeneic murine sarcoma Meth A, which overexpresses mutant p53. Mice were inoculated with a lethal dose (5 × 105 cells injected s.c.) of Meth A tumor cells and vaccinated by i.p. injection 3 days later with 5 × 107 PFU of rMVAp53. The majority of mice remained tumor free and resistant to rechallenge with Meth A tumor cells. We wished to determine whether rMVAp53 immunization could effect the rejection of an established, palpable Meth A tumor. In subsequent experiments, mice were injected with 106 Meth A tumor cells, and treated 6 days later with anti-CTLA-4 Ab (9H10) and rMVAp53. The majority of treated mice had complete tumor regression along with lasting tumor immunity. In vivo Ab depletion confirmed that the antitumor effect was primarily CD8 and to a lesser extent CD4 dependent. These experiments demonstrate the potential of a novel cell-free vaccine targeting p53 in malignancy." @default.
• W1845472102 created "2016-06-24" @default.
• W1845472102 creator A5013466378 @default.
• W1845472102 creator A5022693796 @default.
• W1845472102 creator A5028729406 @default.
• W1845472102 creator A5057057095 @default.
• W1845472102 creator A5057403720 @default.
• W1845472102 creator A5086089087 @default.
• W1845472102 creator A5090861620 @default.
• W1845472102 date "2003-03-15" @default.
• W1845472102 modified "2023-10-12" @default.
• W1845472102 title "CTLA-4 Blockade Enhances the Therapeutic Effect of an Attenuated Poxvirus Vaccine Targeting p53 in an Established Murine Tumor Model" @default.
• W1845472102 cites W1541202713 @default.
• W1845472102 cites W1564086449 @default.
• W1845472102 cites W1756831977 @default.
• W1845472102 cites W1769192511 @default.
• W1845472102 cites W1787464458 @default.
• W1845472102 cites W1874646775 @default.
• W1845472102 cites W1966709711 @default.
• W1845472102 cites W1967880566 @default.
• W1845472102 cites W1970537831 @default.
• W1845472102 cites W1972149015 @default.
• W1845472102 cites W1974565005 @default.
• W1845472102 cites W1977090800 @default.
• W1845472102 cites W1986899481 @default.
• W1845472102 cites W1987155012 @default.
• W1845472102 cites W2010363127 @default.
• W1845472102 cites W2015802333 @default.
• W1845472102 cites W2025506176 @default.
• W1845472102 cites W2030574136 @default.
• W1845472102 cites W2031439967 @default.
• W1845472102 cites W2033537986 @default.
• W1845472102 cites W2041679777 @default.
• W1845472102 cites W2044296969 @default.
• W1845472102 cites W2044309960 @default.
• W1845472102 cites W2048843181 @default.
• W1845472102 cites W2050653614 @default.
• W1845472102 cites W2067721805 @default.
• W1845472102 cites W2071483270 @default.
• W1845472102 cites W2078685026 @default.
• W1845472102 cites W2078760290 @default.
• W1845472102 cites W2079016419 @default.
• W1845472102 cites W2080175986 @default.
• W1845472102 cites W2080692751 @default.
• W1845472102 cites W2080740527 @default.
• W1845472102 cites W2094366129 @default.
• W1845472102 cites W2105017308 @default.
• W1845472102 cites W2125101148 @default.
• W1845472102 cites W2127094135 @default.
• W1845472102 cites W2140460887 @default.
• W1845472102 cites W2143529834 @default.
• W1845472102 cites W2144172655 @default.
• W1845472102 cites W2147597038 @default.
• W1845472102 cites W2149244682 @default.
• W1845472102 cites W2151868151 @default.
• W1845472102 cites W2154271740 @default.
• W1845472102 cites W2155021907 @default.
• W1845472102 cites W2162856391 @default.
• W1845472102 cites W2184646877 @default.
• W1845472102 cites W2262757894 @default.
• W1845472102 cites W2317574355 @default.
• W1845472102 cites W4253422011 @default.
• W1845472102 doi "https://doi.org/10.4049/jimmunol.170.6.3401" @default.
• W1845472102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12626601" @default.
• W1845472102 hasPublicationYear "2003" @default.
• W1845472102 type Work @default.
• W1845472102 sameAs 1845472102 @default.
• W1845472102 citedByCount "75" @default.
• W1845472102 countsByYear W18454721022012 @default.
• W1845472102 countsByYear W18454721022013 @default.
• W1845472102 countsByYear W18454721022014 @default.
• W1845472102 countsByYear W18454721022015 @default.
• W1845472102 countsByYear W18454721022016 @default.
• W1845472102 countsByYear W18454721022017 @default.
• W1845472102 countsByYear W18454721022018 @default.
• W1845472102 countsByYear W18454721022019 @default.
• W1845472102 countsByYear W18454721022020 @default.
• W1845472102 countsByYear W18454721022021 @default.
• W1845472102 countsByYear W18454721022023 @default.
• W1845472102 crossrefType "journal-article" @default.
• W1845472102 hasAuthorship W1845472102A5013466378 @default.
• W1845472102 hasAuthorship W1845472102A5022693796 @default.
• W1845472102 hasAuthorship W1845472102A5028729406 @default.
• W1845472102 hasAuthorship W1845472102A5057057095 @default.
• W1845472102 hasAuthorship W1845472102A5057403720 @default.
• W1845472102 hasAuthorship W1845472102A5086089087 @default.
• W1845472102 hasAuthorship W1845472102A5090861620 @default.
• W1845472102 hasBestOaLocation W18454721021 @default.
• W1845472102 hasConcept C104317684 @default.
• W1845472102 hasConcept C143065580 @default.
• W1845472102 hasConcept C147969180 @default.
• W1845472102 hasConcept C159047783 @default.
• W1845472102 hasConcept C167672396 @default.
• W1845472102 hasConcept C203014093 @default.
• W1845472102 hasConcept C207583985 @default.
• W1845472102 hasConcept C2522874641 @default.
• W1845472102 hasConcept C2777701055 @default.
• W1845472102 hasConcept C2780801004 @default.

• next